The potential role of follicular helper T cells in idiopathic multicentric Castleman disease with and without TAFRO syndrome

被引:8
|
作者
Kurose, Nozomu [1 ]
Guo, Xin [1 ]
Shioya, Akihiro [1 ]
Mizutani, Ken-ichi [1 ]
Kumagai, Motona [1 ]
Fujimoto, Shino [2 ]
Kawabata, Hiroshi [2 ]
Masaki, Yasufumi [2 ]
Takai, Kazue [3 ]
Aoki, Sadao [4 ]
Nakamura, Shigeo [5 ]
Yamada, Sohsuke [1 ]
机构
[1] Dept Pathol & Lab Med, Uchinada, Ishikawa, Japan
[2] Kanazawa Med Univ, Dept Hematol & Immunol, Uchinada, Ishikawa, Japan
[3] Niigata City Gen Hosp, Div Hematol, Niigata, Japan
[4] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Pathophysiol, Niigata, Japan
[5] Nagoya Univ, Dept Pathol & Biol Response, Grad Sch Med, Nagoya, Aichi, Japan
关键词
TAFRO syndrome; Follicular helper T cell; IgG4-related disease; CXCR5; CD40L; DIFFERENTIATION; EXPRESSION; PATHOGENESIS;
D O I
10.1016/j.prp.2019.152563
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Idiopathic multicentric Castleman disease (iMCD) is a systemic inflammatory disease of unknown etiology caused by hypercytokinemia. Recently, TAFRO (thrombocytopenia, gnasarca, fever, renal failure or reticulin fibrosis, and organomegaly) syndrome has been reported, which shows similar histopathological findings to iMCD and factors associated with a poor prognosis. IMCD shows no plasma cell infiltration in the germinal center (GC), but CD38-positive (CD38(+))-plasma cells are observed in the interfollicular area. Our previous report revealed that atrophic change of GC, glomeruloid vascular proliferation, and abnormal proliferation of follicular dendritic cells are more prominent in iMCD with TAFRO (TAFRO +) in comparison to iMCD without TAFRO (TAFRO ). In addition, the numbers of CD38(+) and immunoglobulin G4-positive (IgG4(+)) plasma cells were decreased in the interfollicular area. The roles of T follicular helper cells (Tfh) are well-known to assist B-cell proliferation, maturation, and differentiation . It maintains the formation of GC and is also related in the class switching of IgG isotypes, including IgG4. Thus, we immunohistochemically examined the number of Tfh in GCs in both TAFRO(-) and TAFRO(+) iMCD. The number of Tfh was significantly decreased in TAFRO(-) iMCD (n = 9) and was further decreased in TAFRO(+) iMCD (n = 18) in comparison to non-specific lymphadenopathy (n = 6) and IgG4-related disease (n = 4). These results suggest that decreased Tfh may be one etiology of iMCD.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Follicular Helper T Cells in DiGeorge Syndrome
    Klocperk, Adam
    Parackova, Zuzana
    Bloomfield, Marketa
    Rataj, Michal
    Pokorny, Jan
    Unger, Susanne
    Warnatz, Klaus
    Sediva, Anna
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [42] Indolent T-Lymphoblastic Proliferation in Idiopathic Multicentric Castleman Disease
    Karki, Nabin Raj
    Arfa, Ahmed Samire
    Savage, Natasha
    Kutlar, Abdullah
    ACTA HAEMATOLOGICA, 2022, 145 (02) : 214 - 220
  • [43] The Role of CABIN1 in the Pathogenesis of Idiopathic Multicentric Castleman Disease
    Laczko, Dorottya
    Fajgenbaum, David C.
    Kambayashi, Taku
    BLOOD, 2023, 142
  • [44] Development of T follicular helper cells and their role in disease and immune system
    Eivazi, Sadegh
    Bagheri, Salman
    Hashemzadeh, Mohammad Sadegh
    Ghalavand, Majdedin
    Qamsari, Elmira Safaie
    Dorostkar, Ruhollah
    Yasemi, Maryam
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 84 : 1668 - 1678
  • [45] The role of follicular T helper cells in patients with malignant lymphoid disease
    Zhou, Dong-Ming
    Xu, Yan-Xia
    Zhang, Li-Ying
    Sun, Yu
    Wang, Zi-Yan
    Yuan, Yu-Qing
    Fu, Jin-Xiang
    HEMATOLOGY, 2017, 22 (07) : 412 - 418
  • [46] Peripheral helper-T-cell-derived CXCL13 is a crucial pathogenic factor in idiopathic multicentric Castleman disease
    Harada, Takuya
    Kikushige, Yoshikane
    Miyamoto, Toshihiro
    Uno, Kazuko
    Niiro, Hiroaki
    Kawakami, Atsushi
    Koga, Tomohiro
    Akashi, Koichi
    Yoshizaki, Kazuyuki
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [47] Peripheral helper-T-cell-derived CXCL13 is a crucial pathogenic factor in idiopathic multicentric Castleman disease
    Takuya Harada
    Yoshikane Kikushige
    Toshihiro Miyamoto
    Kazuko Uno
    Hiroaki Niiro
    Atsushi Kawakami
    Tomohiro Koga
    Koichi Akashi
    Kazuyuki Yoshizaki
    Nature Communications, 14
  • [48] Biomarkers and Signaling Pathways Implicated in the Pathogenesis of Idiopathic Multicentric Castleman Disease/Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly (TAFRO) Syndrome
    Sumiyoshi, Remi
    Koga, Tomohiro
    Kawakami, Atsushi
    BIOMEDICINES, 2024, 12 (06)
  • [49] Two cases of idiopathic multicentric Castleman disease with nephrotic syndrome treated with tocilizumab
    Furutera, Norihiro
    Fukunaga, Naoya
    Okita, Jun
    Suzuki, Tomoko
    Suenaga, Yuko
    Oyama, Yuzo
    Aoki, Kohei
    Fukuda, Akihiro
    Nakata, Takeshi
    Uesugi, Noriko
    Daa, Tsutomu
    Hisano, Satoshi
    Shibata, Hirotaka
    CEN CASE REPORTS, 2021, 10 (01) : 35 - 41
  • [50] Two cases of idiopathic multicentric Castleman disease with nephrotic syndrome treated with tocilizumab
    Norihiro Furutera
    Naoya Fukunaga
    Jun Okita
    Tomoko Suzuki
    Yuko Suenaga
    Yuzo Oyama
    Kohei Aoki
    Akihiro Fukuda
    Takeshi Nakata
    Noriko Uesugi
    Tsutomu Daa
    Satoshi Hisano
    Hirotaka Shibata
    CEN Case Reports, 2021, 10 : 35 - 41